PHARMATHENE, INC for PHARMATHENE, INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 17, 2011 | $299,325 | Replaced |
| 3rd Quarter - Amendment (this page) | Jan 26, 2012 | $224,325 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
House and Senate Reauthorization of Pandemic and All-Hazards Preparedness Act (PAHPA; H.R. 2405; S. 1855), FY-2012 Appropriations Continuing resolution (H.R. 2608), FY-2012 Labor-HHS Appropriations, Increased funding for BARDA at HHS, Medical Countermeasures (MCM's) for bioterrorism threats, specifically 2nd generation Anthrax rPA Vaccine and Anthrax Antitoxin.
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCESCA COOK | Sr. VP Policy and Government Affairs |
| MARK EDWARD COOKE | Sr. Director Government Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.